+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Vestibular Diseases Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767921
  • Report
  • April 2019
  • Region: Global
  • 66 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Apsen Farmaceutica SA
  • GenVec Inc
  • Neocutis Inc
  • Novartis AG
  • Pierre Fabre Foundation
  • Sensorion SA
  • MORE
The global clinical trial report- “2019 Vestibular Diseases Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vestibular Diseases. It presents in-depth analysis of Vestibular Diseases clinical trials across markets and companies. The research work is for providing complete understanding into trends in Vestibular Diseases.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Vestibular Diseases clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Vestibular Diseases

The research work is prepared through extensive and continuous research on Vestibular Diseases trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Vestibular Diseases patients are identified
  • The report includes panorama of Vestibular Diseases clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Vestibular Diseases clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Apsen Farmaceutica SA
  • GenVec Inc
  • Neocutis Inc
  • Novartis AG
  • Pierre Fabre Foundation
  • Sensorion SA
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Vestibular Diseases Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Vestibular Diseases Clinical Trials by Region
2.2.2 Average Enrollment of Vestibular Diseases Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Vestibular Diseases Treatment, 2019

3. Region wise Vestibular Diseases Clinical Trials
3.1 Asia Pacific Vestibular Diseases Clinical Trials by Country
3.2 Europe Vestibular Diseases Clinical Trials by Country
3.3 North America Vestibular Diseases Clinical Trials by Country
3.4 Middle East and Africa Vestibular Diseases Clinical Trials by Country
3.5 South and Central America Vestibular Diseases Clinical Trials by Country

4. Vestibular Diseases Clinical Trial Trends
4.1 Start Year wise Vestibular Diseases Clinical Trials
4.2 Phase wise Vestibular Diseases Clinical Trials
4.3 Trial Status wise Vestibular Diseases Clinical Trials
4.4 Trial Type wise Vestibular Diseases Clinical Trials

5. Vestibular Diseases Average Enrollment Trends
5.1 Average Enrollment in Vestibular Diseases Trials by Year
5.2 Average Enrollment in Vestibular Diseases Trials by Phase
5.3 Average Enrollment in Vestibular Diseases Trials by Status
5.4 Average Enrollment in Vestibular Diseases Trials by Type of Trial

6. Companies Participating in Vestibular Diseases Clinical Trials
6.1 Vestibular Diseases Trials by Sponsor Type
6.2 Vestibular Diseases Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Vestibular Diseases Trials- Phase 1
7.2 Vestibular Diseases Trials- Phase 2
7.3 Vestibular Diseases Trials- Phase 3
7.4 Vestibular Diseases Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Vestibular Diseases Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Vestibular Diseases Clinical Trials and Enrolment
Figure 5: Europe - Country wise Vestibular Diseases Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Vestibular Diseases Clinical Trials and Enrolment
Figure 7: North America - Country wise Vestibular Diseases Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Vestibular Diseases Clinical Trials and Enrolment
Figure 9: Vestibular Diseases Clinical Trials by Phase
Figure 10: Vestibular Diseases Clinical Trials by Trial Status
Figure 11: Vestibular Diseases Clinical Trials by Type
Figure 12: Vestibular Diseases Clinical Trials by Sponsor Type
Figure 13: Vestibular Diseases Clinical Trials by Leading Sponsors
Figure 14: Vestibular Diseases Average Enrollment by Phase
Figure 15: Vestibular Diseases Average Enrollment by Trial Status
Figure 16: Vestibular Diseases Average Enrollment by Type
Figure 17: Vestibular Diseases- Average Enrolment by Type of Sponsors
Figure 18: Vestibular Diseases- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Vestibular Diseases Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Vestibular Diseases Clinical Trials and Enrolment
Table 5: Europe - Country wise Vestibular Diseases Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Vestibular Diseases Clinical Trials and Enrolment
Table 7: North America - Country wise Vestibular Diseases Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Vestibular Diseases Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Vestibular Diseases Average Enrollment by Phase
Table 15: Vestibular Diseases Average Enrollment by Trial Status
Table 16: Vestibular Diseases Average Enrollment by Type
Table 17: Vestibular Diseases- Average Enrolment by Type of Sponsors
Table 18: Vestibular Diseases- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Apsen Farmaceutica SA
  • GenVec Inc
  • Neocutis Inc
  • Novartis AG
  • Pierre Fabre Foundation
  • Pingguang Pharmaceutical Group Co Ltd
  • Sensorion SA
  • Simbec Research Ltd
  • SK Chemicals Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll